The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
IL-12p35-Deficient Mice Are Susceptible to Experimental Autoimmune Encephalomyelitis: Evidence for Redundancy in the IL-12 System in the Induction of Central Nervous System Autoimmune Demyelination
Abstract
Experimental autoimmune encephalomyelitis (EAE) serves as a model for multiple sclerosis and is considered a CD4+, Th1 cell-mediated autoimmune disease. IL-12 is a heterodimeric cytokine, composed of a p40 and a p35 subunit, which is thought to play an important role in the development of Th1 cells and can exacerbate EAE. We induced EAE with myelin oligodendrocyte glycoprotein (MOG) peptide 35–55 (MOG35–55) in C57BL/6 mice and found that while IL-12p40-deficient (−/−) mice are resistant to EAE, IL-12p35−/− mice are susceptible. Typical spinal cord mononuclear cell infiltration and demyelination were observed in wild-type and IL-12p35−/− mice, whereas IL-12p40−/− mice had normal spinal cords. A Th1-type response to MOG35–55 was observed in the draining lymph node and the spleen of wild-type mice. A weaker MOG35–55-specific Th1 response was observed in IL-12p35−/− mice, with lower production of IFN-γ. By contrast, a Th2-type response to MOG35–55 correlated with disease resistance in IL-12p40−/− mice. Production of TNF-α by microglia, CNS-infiltrating macrophages, and CD4+ T cells was detected in wild-type and IL-12p35−/−, but not in IL-12p40−/−, mice. In addition, NO production was higher in IL-12p35−/− and wild-type mice than in IL-12p40−/− mice. These data demonstrate a redundancy of the IL-12 system in the induction of EAE and suggest that p40-related heterodimers, such as the recently cloned IL-23 (p40p19), may play an important role in disease pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oppmann, B., Lesley, R., Blom, B., Timans, J. C., Xu, Y., Hunte, B., Vega, F., Yu, N., Wang, J., Singh, K., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00070-4 · Cited by 2,822
Parham, C., Chirica, M., Timans, J., Vaisberg, E., Travis, M., Cheung, J., Pflanz, S., Zhang, R., Singh, K. P., Vega, F., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5699 · Cited by 1,296
THE INTERLEUKIN-12/INTERLEUKIN-12-RECEPTOR SYSTEM: Role in Normal and Pathologic Immune Responses
Gately, M. K., Renzetti, L. M., Magram, J., Stern, A. S., Adorini, L., Gubler, U., & Presky, D. H. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.495 · Cited by 1,231
Ferber, I. A., Brocke, S., Taylor-Edwards, C., Ridgway, W., Dinisco, C., Steinman, L., Dalton, D., & Fathman, C. G. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.1.5 · Cited by 989
IL-12-Deficient Mice Are Defective in IFNγ Production and Type 1 Cytokine Responses
Magram, J., Connaughton, S. E., Warrier, R. R., Carvajal, D. M., Wu, C.-Y., Ferrante, J., Stewart, C., Sarmiento, U., Faherty, D. A., & Gately, M. K. (1996) · Immunity · doi:10.1016/s1074-7613(00)80413-6 · Cited by 989
Role of T-bet in Commitment of T H 1 Cells Before IL-12-Dependent Selection
Mullen, A. C., High, F. A., Hutchins, A. S., Lee, H. W., Villarino, A. V., Livingston, D. M., Kung, A. L., Cereb, N., Yao, T.-P., Yang, S. Y., et al. (2001) · Science · doi:10.1126/science.1059835 · Cited by 825
Interleukin-12: A Cytokine at the Interface of Inflammation and Immunity
Trinchieri, G. (1998) · Advances in Immunology · doi:10.1016/s0065-2776(08)60387-9 · Cited by 760
Ford, A. L., Goodsall, A. L., Hickey, W. F., & Sedgwick, J. D. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.9.4309 · Cited by 631
Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12.
Leonard, J. P., Waldburger, K. E., & Goldman, S. J. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.1.381 · Cited by 547
Interferon‐γ confers resistance to experimental allergic encephalomyelitis
Krakowski, M., & Owens, T. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260735 · Cited by 471
Mattner, F., Magram, J., Ferrante, J., Launois, P., Padova, K. D., Behin, R., Gately, M. K., Louis, J. A., & Alber, G. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260722 · Cited by 469
An Interleukin (IL)-10/IL-12 Immunoregulatory Circuit Controls Susceptibility to Autoimmune Disease
Segal, B. M., Dwyer, B. K., & Shevach, E. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.537 · Cited by 469
Brain Dendritic Cells and Macrophages/Microglia in Central Nervous System Inflammation
Fischer, H.-G., & Reichmann, G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2717 · Cited by 411
Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12
Becher, B., Durell, B. G., & Noelle, R. J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15751 · Cited by 386
Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12
Becher, B., Durell, B. G., & Noelle, R. J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215751 · Cited by 346
Cooper, A. M., Kipnis, A., Turner, J., Magram, J., Ferrante, J., & Orme, I. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1322 · Cited by 304
Wiekowski, M. T., Leach, M. W., Evans, E. W., Sullivan, L., Chen, S.-C., Vassileva, G., Bazan, J. F., Gorman, D. M., Kastelein, R. A., Narula, S., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7563 · Cited by 295
Chen, H., & Paul, W. E. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.5.2240 · Cited by 286
Jankovic, D., Kullberg, M. C., Hieny, S., Caspar, P., Collazo, C. M., & Sher, A. (2002) · Immunity · doi:10.1016/s1074-7613(02)00278-9 · Cited by 252
Assessment of Animal Models for MS and Demyelinating Disease in the Design of Rational Therapy
Steinman, L. (1999) · Neuron · doi:10.1016/s0896-6273(00)81107-1 · Cited by 245
Willenborg, D. O., Fordham, S. A., Staykova, M. A., Ramshaw, I. A., & Cowden, W. B. (1999) · PubMed · Cited by 241
Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1
Eugster, H.-P., Frei, K., Bachmann, R., Bluethmann, H., Lassmann, H., & Fontana, A. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199902)29:02<626::aid-immu626>3.0.co;2-a · Cited by 213
Willenborg, D. O., Fordham, S. A., Staykova, M. A., Ramshaw, I. A., & Cowden, W. B. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.10.5278 · Cited by 212
Further Checkpoints in Th1 Development
Robinson, D. S., & O'Garra, A. (2002) · Immunity · doi:10.1016/s1074-7613(02)00331-x · Cited by 204
Probert, L. (2000) · Brain · doi:10.1093/brain/123.10.2005 · Cited by 190
Aloisi, F., Simone, R. D., Cabezas, S. C., Penna, G., & Adorini, L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.1705 · Cited by 167
Constantinescu, C. S., Wysocka, M., Hilliard, B. A., Ventura, E. S., Lavi, E., Trinchieri, G., & Rostami, A. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.5097 · Cited by 164
Self-citationJuedes, A. E., Hjelmström, P., Bergman, C. M., Neild, A. L., & Ruddle, N. H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.419 · Cited by 161
Our shifting understanding of the role of nitric oxide in autoimmune encephalomyelitis: a review
Willenborg, D. O., Staykova, M. A., & Cowden, W. B. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00212-x · Cited by 137
Lehmann, J., Bellmann, S., Werner, C., Schröder, R., Schütze, N., & Alber, G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.9.5304 · Cited by 118
IL‐12‐Deficient Mice Are Defective but Not Devoid of Type 1 Cytokine Responses
Magram, J., SFARRA, J., Connaughton, S. E., Faherty, D. A., Warrier, R. R., Carvajal, D. M., Wu, C. Y., Stewart, C. L., Sarmiento, U. M., & Gately, M. K. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb52655.x · Cited by 117
Alloantigen-Reactive Th1 Development in IL-12-Deficient Mice
Piccotti, J. R., Li, K., Chan, S. Y., Ferrante, J., Magram, J., EICHWALD, E. J., & Bishop, D. K. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1132 · Cited by 117
Interleukin-12 induces relapse in experimental allergic encephalomyelitis in the Lewis rat.
Smith, T., Hewson, A. K., Kingsley, C. I., Leonard, J. P., & Cuzner, M. L. (1997) · Europe PMC (PubMed Central) · Cited by 102
Chang, J. T., Shevach, E. M., & Segal, B. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.6.969 · Cited by 98
Calida, D. M., Constantinescu, C. S., Purev, E., Zhang, G., Ventura, E. S., Lavi, E., & Rostami, A. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.2.723 · Cited by 90
Self-citationBenson, J., Campbell, K., Guan, Z., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10738 · Cited by 84
Contrasting roles of IL-12p40 and IL-12p35 in the development of hapten-induced colitis
Camoglio, L., Juffermans, N. P., Peppelenbosch, M. P., Velde, A. A. T., ten Kate, F. J. W., van Deventer, S. J. H., & Köpf, M. (2002) · European Journal of Immunology · Cited by 74
Helper T cell differentiation, inside and out
Reiner, S. L. (2001) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00226-0 · Cited by 61
Constantinescu, C. S., Hilliard, B. A., Ventura, E. S., Wysocka, M., Showe, L. C., Lavi, E., Fujioka, T., Scott, P., Trinchieri, G., & Rostami, A. M. (2001) · Clinical Immunology · doi:10.1006/clim.2000.4944 · Cited by 51
Self-citationIndirect IL-4 Pathway in Type 1 Immunity
Karulin, A. Y., Hesse, M. D., Yip, H. C., & Lehmann, P. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.545 · Cited by 38
Selmaj, K. W., Walczak, A., Mycko, M. P., Berkowicz, T., Kohno, T., & Raine, C. S. (1998) · European Journal of Immunology · Cited by 37
T cells, cytokines, and autoantigens in multiple sclerosis
Gran, B., & Rostami, A. M. (2001) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-001-0029-3 · Cited by 26
Self-citation
Cited by
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
“However, IFN- (8), IFN- R (9), IL-12R 2 (10), and IL12p35 mice (11, 12), which all lack critical components of the Th1–IFN- pathway, are highly susceptible to inflammatory autoimmune diseases, questioning whether IFN- – producing T cells have an essential role in autoimmune pathogenesis.”
BackgroundResultThe PD‐1 pathway in tolerance and autoimmunity
Francisco, L. M., Sage, P. T., & Sharpe, A. H. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00923.x · Cited by 2,300
The inhibitory cytokine IL-35 contributes to regulatory T-cell function
Collison, L. W., Workman, C. J., Kuo, T. T., Boyd, K., Wang, Y., Vignali, K. M., Cross, R., Sehy, D., Blumberg, R. S., & Vignali, D. A. A. (2007) · Nature · doi:10.1038/nature06306 · Cited by 2,066
Metadata
- Authors
- Gran, B., Zhang, G.-X., Yu, S., Li, J., Chen, X.-H., Ventura, E. S., Kamoun, M., & Rostami, A.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-12
- Volume
- 169
- Issue
- 12
- Pages
- 7104-7110
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1525680491
- Cited by
- 405
- References
- 42
- FWCI
- 8.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.